XML 51 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Restricted and Performance Share-Based Activity
A summary of non-vested restricted share-based activity for the years ended December 31, 2021, 2020, and 2019 follows:
Unvested SharesWeighted Average Grant Date Fair Value
Outstanding at December 31, 2018703,024 $16.18 
Granted/Earned801,751 12.70 
Forfeited/Cancelled(272,706)12.97 
Vested(456,183)16.20 
Outstanding at December 31, 2019775,886 $13.78 
Granted/Earned1,387,059 6.87 
Forfeited/Cancelled(162,635)13.77 
Vested(552,943)12.78 
Outstanding at December 31, 20201,447,367 $9.75 
Granted/Earned1,009,085 39.90 
Forfeited/Cancelled(77,844)47.40 
Vested(723,212)42.88 
Outstanding at December 31, 20211,655,396 $11.55 
Schedule of Stock Options, Valuation Assumptions
The following table sets forth the assumptions used by the Company to estimate the fair value of stock options granted during the year ended December 31, 2019. No stock options were granted during the years ended December 31, 2021 and 2020.
2019
Expected volatility60 %
Risk-free interest rate
2.30% - 2.40%
Expected dividends— 
Average expected term (years)4
Fair value of stock options granted
$4.83 - $6.41
Schedule of Stock Options Activity
A summary of stock option activity for the years ended December 31, 2021, 2020, and 2019 follows:
OptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (years)
Outstanding at December 31, 2018512,687 $13.03 9.8
Granted2,256,500 13.00 9.2
Exercised— 
Forfeited/Cancelled— 
Outstanding at December 31, 20192,769,187 $13.02 9.0
Granted— 
Exercised(4,199)20.24 5.8
Forfeited/Cancelled(4,473)19.00 4.8
Outstanding at December 31, 20202,760,515 $12.88 8.0
Granted— 
Exercised(9,155)6.28 7.7
Forfeited/Cancelled(366,500)13.42 7.2
Outstanding at December 31, 2021 (1)
2,384,860 $12.82 7.0
(1) Of the outstanding stock options, 1,588,186 were exercisable as of December 31, 2021.